POINT Biopharma Global Inc. Quarterly Return On Equity in % from Q4 2020 to Q3 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
POINT Biopharma Global Inc. quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q3 2023.
  • POINT Biopharma Global Inc. Return On Equity for the quarter ending September 30, 2023 was 21.1 %.
  • POINT Biopharma Global Inc. annual Return On Equity for 2022 was 31.4 %.
  • POINT Biopharma Global Inc. annual Return On Equity for 2021 was -21.9 %, a 82.7% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2023 21.1 +52.2 Jul 1, 2023 Sep 30, 2023
Q2 2023 22.7 +52.2 Apr 1, 2023 Jun 30, 2023
Q1 2023 26.5 +48 Jan 1, 2023 Mar 31, 2023
Q4 2022 31.4 +53.3 Oct 1, 2022 Dec 31, 2022
Q3 2022 -31.1 -6.1 -24.4% Jul 1, 2022 Sep 30, 2022
Q2 2022 -29.5 -2.76 -10.3% Apr 1, 2022 Jun 30, 2022
Q1 2022 -21.5 +80.8 +79% Jan 1, 2022 Mar 31, 2022
Q4 2021 -21.9 +104 +82.7% Oct 1, 2021 Dec 31, 2021
Q3 2021 -25 Jul 1, 2021 Sep 30, 2021
Q2 2021 -26.8 Apr 1, 2021 Jun 30, 2021
Q1 2021 -102 Jan 1, 2021 Mar 31, 2021
Q4 2020 -126 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.